Z-VAD-FMK

Z-VAD-FMK

Contact us: [email protected]

Z-VAD-FMK
A1902-5 5 mg
EUR 268.8
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK
A1902-5.1 10 mM (in 1mL DMSO)
EUR 268.8
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK
HY-16658B 10mg
EUR 786

Z-VAD-FMK
13300 1 mg
EUR 102

Z-VAD-FMK
1140-1 each
EUR 352.8

Z-VAD-FMK
1140-5 each
EUR 966

Z-VAD(OMe)-FMK
HY-16658 10mg
EUR 472.8

Z-VAD(OMe)-FMK
27313 5 mg
EUR 480
Description: Z-VAD(OMe)-FMK is a cell permeable, irreversible pan-caspase inhibitor and anti-apoptotic agent. It has been shown to inhibit Fas-mediated apoptosis in Jurkat T cells and apoptosis in THP.1 cells induced by diverse stimuli (including cycloheximide, thapsigargin, etoposide and staurosporine). Inhibits caspases 1, 3, 4, and 7.

Z-VAD-FMK, cell permeable
GL1523-1MG 1 mg
EUR 330

Z-VAD-FMK, cell permeable
GL1523-5MG 5 mg
EUR 950.4

Z-VAD-FMK, Methyl Ester
27017 1 mg
EUR 165
Description: Z-VAD(OMe)-FMK is a cell permeable, irreversible pan-caspase inhibitor and anti-apoptotic agent. It has been shown to inhibit Fas-mediated apoptosis in Jurkat T cells and apoptosis in THP.1 cells induced by diverse stimuli (including cycloheximide, thapsigargin, etoposide and staurosporine). Inhibits caspases 1, 3, 4, and 7._x000D__x000D_ _x000D_

Caspase-Family Inhibitor Z-VAD-FMK
1010-100 each
EUR 235.2

Caspase-Family Inhibitor Z-VAD-FMK
1010-20C each
EUR 235.2

SRB-VAD-FMK [Sulforhodamine B-VAD-FMK]
13472 25 Tests
EUR 158.4

SRB-VAD-FMK [Sulforhodamine B-VAD-FMK]
13482 100 Tests
EUR 211

Z-VAD-FMK (Pan-specific caspase inhibitor)
SIH-557-1MG 1 mg
EUR 231.6
Description: The substance Z-VAD-FMK is a pan-specific caspase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is lyophilized solid or wax which is May be dissolved in DMSO (10 mg/ml).

FAM-VAD-FMK
13470 25 Tests
EUR 158.4

TF4-VAD-FMK
13471 25 Tests
EUR 158.4

Biotin-VAD-FMK
HY-100894 1mg
EUR 1216.8

FAM-VAD-FMK
13484 100 Tests
EUR 211

FITC-VAD-FMK
9497-100 each
EUR 430.8

Biotin-VAD-FMK
1123-20C each
EUR 392.4

mFluor™ 450-VAD-FMK
13475 25 Tests
EUR 158.4

mFluor™ 510-VAD-FMK
13476 25 Tests
EUR 158.4

Z-YVAD-FMK
A8955-1 1 mg
EUR 282
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-YVAD-FMK
A8955-5 5 mg
EUR 616.8
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-YVAD-FMK
A8955-5.1 10 mM (in 1mL DMSO)
EUR 1326
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-FA-FMK
A8170-1 1 mg
EUR 142.8
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-10 10 mg
EUR 560.4
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-25 25 mg
EUR 616.8
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-5 5 mg
EUR 338.4
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-5.1 10 mM (in 1mL DMSO)
EUR 408
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-S Evaluation Sample
EUR 97.2
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-DEVD-FMK
A1920-1 1 mg
EUR 135.6
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-10 10 mg
EUR 408
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-25 25 mg
EUR 616.8
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-5 5 mg
EUR 268.8
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-5.1 10 mM (in 1mL DMSO)
EUR 351.6
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-S Evaluation Sample
EUR 97.2
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DQMD-FMK
A1921-1 1 mg
EUR 135.6
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-10 10 mg
EUR 408
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-25 25 mg
EUR 616.8
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-5 5 mg
EUR 268.8
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-5.1 10 mM (in 1mL DMSO)
EUR 518.4
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-S Evaluation Sample
EUR 97.2
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-VDVAD-FMK
A1922-1 1 mg
EUR 212.4
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK
A1922-10 10 mg
EUR 756
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK
A1922-25 25 mg
EUR 1173.6
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK
A1922-5 5 mg
EUR 477.6
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK
A1922-S Evaluation Sample
EUR 97.2
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VEID-FMK
A1923-1 1 mg
EUR 212.4
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK
A1923-10 10 mg
EUR 756
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK
A1923-25 25 mg
EUR 1173.6
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK
A1923-5 5 mg
EUR 477.6
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK
A1923-S Evaluation Sample
EUR 97.2
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-WEHD-FMK
A1924-1 1 mg
EUR 135.6
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK
A1924-10 10 mg
EUR 408
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK
A1924-25 25 mg
EUR 616.8
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK
A1924-5 5 mg
EUR 268.8
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-IETD-FMK
B3232-1 1 mg
EUR 393.6
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-IETD-FMK
B3232-5 5 mg
EUR 547.2
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-IETD-FMK
B3232-5.1 10 mM (in 1mL DMSO)
EUR 1201.2
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-LEHD-FMK
B3233-1 1 mg
EUR 420
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Z-LEHD-FMK
B3233-5 5 mg
EUR 1054.8
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Z-VRPR-FMK
GL3755-1MG 1 mg
EUR 702

Z-VRPR-FMK
GL3755-500UG 500 ug
EUR 426

Z-DEVD-FMK
HY-12466 10mg
EUR 471.6

Z-IETD-FMK
HY-101297 5mg
EUR 555.6

Z-DEVD-FMK
13303 1 mg
EUR 102

Z-IETD-FMK
13305 1 mg
EUR 102

Z-LETD-FMK
13307 1 mg
EUR 102

Z-AEVD-FMK
B1162-1 each
EUR 405.6

Z-AEVD-FMK
B1162-5 each
EUR 1096.8

Z-VRPR-FMK
B1238-1000 each
EUR 1096.8

Z-VRPR-FMK
B1238-250 each
EUR 405.6

Z-YVAD-FMK
1141-1 each
EUR 405.6

Z-YVAD-FMK
1141-5 each
EUR 966

Z-VDVAD-FMK
1142-1 each
EUR 366

Z-VDVAD-FMK
1142-5 each
EUR 966

Z-DEVD-FMK
1143-1 each
EUR 379.2

Z-DEVD-FMK
1143-5 each
EUR 966

Z-LEVD-FMK
1144-1 each
EUR 379.2

Z-LEVD-FMK
1144-5 each
EUR 966

Z-VEID-FMK
1146-1 each
EUR 366

Z-VEID-FMK
1146-5 each
EUR 966

Z-IETD-FMK
1148-1 each
EUR 392.4

Z-IETD-FMK
1148-5 each
EUR 940.8

Z-LEHD-FMK
1149-1 each
EUR 379.2

Z-LEHD-FMK
1149-5 each
EUR 920.4

Z-ATAD-FMK
1152-1 each
EUR 418.8

Z-ATAD-FMK
1152-5 each
EUR 1096.8

Z-FA-FMK
1986-1 each
EUR 176.4

Z-FA-FMK
1986-5 each
EUR 444

Z-DEVD-FMK
27314 5 mg
EUR 215
Description: Caspase-3 Inhibitor

Z-DQMD-FMK
27666-1 5 mg
EUR 215
Description: Z-DQMD-FMK is a synthetic peptide that irreversibly inhibits the activity of Caspase-3. Inhibits MG 132-induced small cell lung cancer cell death in vitro. Z-DQMD-FMK can be used for both in vitro and in vivo studies--see note for using this product in vitro.

Z-DQMD-FMK
27666-2 10 mg
EUR 325
Description: Z-DQMD-FMK is a synthetic peptide that irreversibly inhibits the activity of Caspase-3. Inhibits MG 132-induced small cell lung cancer cell death in vitro. Z-DQMD-FMK can be used for both in vitro and in vivo studies--see note for using this product in vitro.

Z-DQMD-FMK
27666-3 25 mg
EUR 500
Description: Z-DQMD-FMK is a synthetic peptide that irreversibly inhibits the activity of Caspase-3. Inhibits MG 132-induced small cell lung cancer cell death in vitro. Z-DQMD-FMK can be used for both in vitro and in vivo studies--see note for using this product in vitro.

Z-FA-FMK
27667-1 5 mg
EUR 290

Z-FA-FMK
27667-2 25 mg
EUR 500

Z-FA-FMK
27667-3 10 mg
EUR 440

Z-VDVAD-FMK
27668-1 5 mg
EUR 380
Description: Z-VDVAD-FMK is a synthetic peptide that irreversibly inhibits the activity of caspase-2. It attenuates oxyhemoglobin-induced cleavage of PARP and apoptosis in endothelial cells. Z-VDVAD-FMK can be used for both in vitro and in vivo studies--see note for using this product in vitro.

Z-VDVAD-FMK
27668-2 10 mg
EUR 625
Description: Z-VDVAD-FMK is a synthetic peptide that irreversibly inhibits the activity of caspase-2. It attenuates oxyhemoglobin-induced cleavage of PARP and apoptosis in endothelial cells. Z-VDVAD-FMK can be used for both in vitro and in vivo studies--see note for using this product in vitro.

Z-VEID-FMK
27669-1 5 mg
EUR 380
Description: Z-VEID-FMK is a synthetic peptide that irreversibly inhibits activity of VEID-dependent caspases (e.g., caspase-6). The inhibitor is designed as a methyl ester to facilitate cell permeability. Can be used for both in vitro and in vivo studies--see note for using this product in vitro.

Z-VEID-FMK
27669-2 10 mg
EUR 625
Description: Z-VEID-FMK is a synthetic peptide that irreversibly inhibits activity of VEID-dependent caspases (e.g., caspase-6). The inhibitor is designed as a methyl ester to facilitate cell permeability. Can be used for both in vitro and in vivo studies--see note for using this product in vitro.

Calpain Inhibitor, Z-LLY-FMK
B1506-1000 each
EUR 405.6

Calpain Inhibitor, Z-LLY-FMK
B1506-250 each
EUR 261.6

Caspase-8 Inhibitor Z-IETD-FMK
B4096-.02 20 µl (10 mM)
EUR 234
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Caspase-8 Inhibitor Z-IETD-FMK
B4096-.1 100 µl (2 mM)
EUR 234
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Caspase-9 Inhibitor Z-LEHD-FMK
B4573-.02 20 µl (10 mM)
EUR 234
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Caspase-9 Inhibitor Z-LEHD-FMK
B4573-.1 100 µl (2 mM)
EUR 234
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Caspase-3 inhibitor, Z-DQMD-FMK
2782-1 each
EUR 170.4

Caspase-3 inhibitor, Z-DQMD-FMK
2782-5 each
EUR 496.8

Caspase-3 Inhibitor Z-DEVD-FMK
1009-100 each
EUR 248.4

Caspase-3 Inhibitor Z-DEVD-FMK
1009-20C each
EUR 248.4

Caspase-6 Inhibitor Z-VEID-FMK
1011-100 each
EUR 222

Caspase-6 Inhibitor Z-VEID-FMK
1011-20C each
EUR 222

Caspase-1 Inhibitor Z-YVAD-FMK
1012-100 each
EUR 235.2

Caspase-1 Inhibitor Z-YVAD-FMK
1012-20C each
EUR 235.2

Caspase-8 Inhibitor Z-IETD-FMK
1064-100 each
EUR 235.2

Caspase-8 Inhibitor Z-IETD-FMK
1064-20C each
EUR 235.2

Caspase-2 Inhibitor Z-VDVAD-FMK
1073-100 each
EUR 222

Caspase-2 Inhibitor Z-VDVAD-FMK
1073-20C each
EUR 222

Caspase-9 Inhibitor Z-LEHD-FMK
1074-100 each
EUR 248.4

Caspase-9 Inhibitor Z-LEHD-FMK
1074-20C each
EUR 248.4

Caspase-12 Inhibitor Z-ATAD-FMK
1079-100 each
EUR 261.6

Caspase-12 Inhibitor Z-ATAD-FMK
1079-20C each
EUR 261.6

Caspase-5 Inhibitor Z-WEHD-FMK
1100-100 each
EUR 235.2

Caspase-5 Inhibitor Z-WEHD-FMK
1100-20C each
EUR 235.2

Caspase-4 Inhibitor Z-LEVD-FMK
1108-100 each
EUR 222

Caspase-4 Inhibitor Z-LEVD-FMK
1108-20C each
EUR 222

EZSolution? Calpain Inhibitor, Z-LLY-FMK
1125-20C each
EUR 222

EMAP-II Inhibitor Z-ASTD-FMK
1127-20C each
EUR 314.4

Cathepsin B&L Inhibitor Z-Phe-Phe-FMK
1126-20C each
EUR 274.8

Anti-DYKDDDDK Antibody | MFLG-45A-Z
MFLG-45A-Z 0.1 mg
EUR 348
Description:

Anti-DYKDDDDK Antibody | MFLG-45A-Z | Immunology Consultants Laboratory

Host: Mouse

Format: Unconjugated AP

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Anti-DYKDDDDK Antibody | RFLG-45A-Z
RFLG-45A-Z 0.1 mg
EUR 348
Description:

Anti-DYKDDDDK Antibody | RFLG-45A-Z | Immunology Consultants Laboratory

Host: Rabbit

Format: Unconjugated AP

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Anti-DYKDDDDK Antibody | RFLG-45B-Z
RFLG-45B-Z 0.1 mg
EUR 363
Description:

Anti-DYKDDDDK Antibody | RFLG-45B-Z | Immunology Consultants Laboratory

Host: Rabbit

Format: Biotin Conjugated

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Anti-DYKDDDDK Antibody | RFLG-45F-Z
RFLG-45F-Z 0.1 mg
EUR 363
Description:

Anti-DYKDDDDK Antibody | RFLG-45F-Z | Immunology Consultants Laboratory

Host: Rabbit

Format: FITC Conjugated

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Anti-DYKDDDDK Antibody | RFLG-45P-Z
RFLG-45P-Z 0.1 mg
EUR 379
Description:

Anti-DYKDDDDK Antibody | RFLG-45P-Z | Immunology Consultants Laboratory

Host: Rabbit

Format: HRP Conjugated

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Anti-GFP Antibody | RGFP-45A-Z
RGFP-45A-Z 0.1 mg
EUR 355
Description:

Anti-GFP Antibody | RGFP-45A-Z | Immunology Consultants Laboratory

Host: Rabbit

Format: Unconjugated AP

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Anti-GST Antibody | RGST-45A-Z
RGST-45A-Z 0.1 mg
EUR 197
Description:

Anti-GST Antibody | RGST-45A-Z | Immunology Consultants Laboratory

Host: Rabbit

Format: Unconjugated AP

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Anti-GST Antibody | RGST-45B-Z
RGST-45B-Z 0.1 mg
EUR 268
Description:

Anti-GST Antibody | RGST-45B-Z | Immunology Consultants Laboratory

Host: Rabbit

Format: Biotin Conjugated

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Anti-GST Antibody | RGST-45F-Z
RGST-45F-Z 0.1 mg
EUR 268
Description:

Anti-GST Antibody | RGST-45F-Z | Immunology Consultants Laboratory

Host: Rabbit

Format: FITC Conjugated

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Anti-GST Antibody | RGST-45P-Z
RGST-45P-Z 0.1 mg
EUR 308
Description:

Anti-GST Antibody | RGST-45P-Z | Immunology Consultants Laboratory

Host: Rabbit

Format: HRP Conjugated

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

Z-VAD-FMK